Header Logo

Connection

MICHELLE A FANALE to New Zealand

Back to Details
This is a "connection" page, showing publications MICHELLE A FANALE has written about New Zealand.
MICHELLE A FANALE
Connection Strength
0.033
New Zealand
  1. Dulanermin with rituximab in patients with relapsed indolent B-cell lymphoma: an open-label phase 1b/2 randomised study. Lancet Haematol. 2015 Apr; 2(4):e166-74.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.